Our company news

Smooth Drug Development February 2021 News Release

Published on Tuesday March 09, 2021

We are working on the following new projects: • We signed a WO for CTD modules preparation with our global Sponsor. • We signed 2 contracts for specification documents

Read more →

Smooth Drug Development January 2021 News Release

Published on Tuesday February 02, 2021

We are happy to present our new signed projects: • Contract for CTA submission of the final report with a new Sponsor. • Agreement for a bioequivalence study (INN: Dutasteride + Tamsulosin).

Read more →

Smooth Drug Development December 2020 News Release

Published on Saturday January 02, 2021

New contracts were signed in December: • A contract for submission of the final report to the Ministry of Health of the Russian Federation. • Medical writing agreement with our long-term Sponsor.

Read more →

Smooth Drug Development November 2020 News Release

Published on Thursday December 03, 2020

New projects started in November: • Bioequivalence trial (INN: Azacitidine). • Medical writing project (INN: Amtolmetin guacil).

Read more →

Smooth Drug Development October 2020 News Release

Published on Tuesday November 03, 2020

We were working on the following new projects in October: • We signed a contract for data management and medical writing project of clinical study in Russia.

Read more →

Smooth Drug Development September 2020 News Release

Published on Tuesday October 06, 2020

We were working on the following new projects in September: • Observational trial is being initiated in dermatology • We signed a contract for a bioequivalence study (INN: Paracetamol) with long-term sponsor

Read more →

Smooth Drug Development August 2020 News Release

Published on Sunday September 06, 2020

We were working on the following new projects in August: • We are in the process of final negotiation of the contract for a BE study with a Czech company

Read more →

Smooth Drug Development July 2020 News Release

Published on Thursday August 06, 2020

We were working on the following new projects in July: • Our company signed a contract for a BE study (INN: Drotaverine) from a big Russian pharma • We finalized a contract for III phase study in patients with arthrosis • We won a tender performed by a leading Russian vaccine company for full services projects

Read more →

Smooth Drug Development June 2020 News Release

Published on Tuesday July 07, 2020

The projects are moving regardless the pandemic situation:Nimesulide phase II study data base is lockedCTA was performed in our phase II study in COVID-19, SIVs are performedLast patient last visit was performed in our phase III PID study in childrenCSR in etoricoxib trial was submitted to MoHDysmenorrhoea pain phase III study is initiatedClinical part in schizophrenia phase III is close to an endClose out visit was performed in Erlotinib trial

Read more →

Approach to clinical trials during pandemic COVID-19

Published on Wednesday July 01, 2020

Measures to promote patients safety during COVID-19 pandemic include: Direct to patients shipment of investigational drug

Read more →

Smooth Drug Development May 2020 News Release

Published on Saturday June 06, 2020

We were working on the following new projects in May: Smooth Drug Development signed several contracts for medical writing

Read more →

March news on Smooth Drug Development

Published on Monday April 06, 2020

Smooth Drug Development is happy to share its March news

Read more →

Smooth Drug Development work during COVID-19

Published on Monday March 23, 2020

COVID-19; Smooth Drug Development

Read more →

Smooth Drug Development January and February 2020 News Release

Published on Sunday March 01, 2020

Smooth Drug Development clinical trials in January and February 2020

Read more →

Smooth Drug Development November 2019 News Release

Published on Saturday November 30, 2019

Smooth Drug Development clinical trials in November

Read more →